The U.S. Supreme Court denied taking up Sandoz’s petition for it to review earlier decisions that had favoured Amgen in the long-running patent litigation. Biosimilar Etanercept is now barred until 2029 in the US. In 2019, New Jersey federal district court ruled in favor of the Amgen, though Sandoz appealed, the U.S. Court of Appeals […]